-
401
OCT predictors of retinal atrophy in neovascular age-related macular degeneration treated with aflibercept
Published 2025-04-01“…AIM: To identify optical coherence tomography (OCT) features present at the diagnosis of neovascular age-related macular degeneration (nAMD) that could predict retinal atrophy (RA) and visual performance in patients treated with intravitreal aflibercept. METHODS: OCT data collected at the time of nAMD diagnosis (T0), after the first (T1) and third (T2) intravitreal aflibercept injection, and 5y post-diagnosis (T3) were analyzed. …”
Get full text
Article -
402
Methylation-based biological age and cardiotoxicity risk in breast cancer patients treated with trastuzumab
Published 2025-05-01“…Epigenetic clocks and circulating leukocyte subsets were derived from MethylationEPIC BeadChip data, and candidate SNPs were measured using the Global Screening Array. …”
Get full text
Article -
403
Primary prevention of cardiotoxicity in cancer patients treated with fluoropyrimidines: a randomized controlled trial
Published 2025-05-01“…Follow-up was 6 months. Data were analyzed using Kaplan–Meier survival function with log-rank test and ROC-analyses. …”
Get full text
Article -
404
Cytokine Pattern of T Lymphocytes in Acute Schistosomiasis mansoni Patients following Treated Praziquantel Therapy
Published 2013-01-01“…Interestingly, we have observed that patients treated with praziquantel showed increased values of lymphocytes as compared with noninfected group (NI) or ACT groups. …”
Get full text
Article -
405
Impact of HLA alloimmunization on clinical outcomes of severe aplastic anemia treated with immunosuppressive therapy
Published 2025-06-01“…Of 444 patients with severe AA treated with immunosuppressive therapy (IST), 99 (22%) had HLA alloimmunization. …”
Get full text
Article -
406
Durvalumab activity in previously treated patients who stopped durvalumab without disease progression
Published 2020-10-01“…Background Limited data exist on potential clinical benefit with anti-programmed cell death ligand-1 (PD-L1) retreatment in patients who stop initial therapy for reasons other than disease progression or toxicity and develop disease progression while off treatment.Patients and methods NCT01693562 was a phase I/II study evaluating durvalumab monotherapy in advanced solid tumors. …”
Get full text
Article -
407
Cytokine profile of COVID-19 convalescent plasma and its relationship to outcome of treated patients
Published 2025-04-01“…Materials and methods. The study included data from 111 patients with COVID-19 who received CCP. …”
Get full text
Article -
408
CYP2D6 genotype and outcome in tamoxifen treated early breast cancer
Published 2025-07-01“…Clinical information was collected from medical records. Data on endocrine treatment, use of CYP2D6 inhibitors was retrieved from the Swedish Prescribed Drug Register. …”
Get full text
Article -
409
High-resolution analysis of the treated coeliac disease microbiome reveals strain-level variation
Published 2025-12-01“…CeD onset results from a multifaceted interplay of genetic and environmental factors. While recent data show that alterations in gut microbiome composition could play an important role, many current studies are constrained by small sample sizes and limited resolution.Methods To address these limitations, we analyzed fecal gut microbiota from two Dutch cohorts, CeDNN (128 treated CeD patients (tCeD), 106 controls) and the Lifelines Dutch Microbiome Project (24 self-reported tCeD, 654 controls), using shotgun metagenomic sequencing. …”
Get full text
Article -
410
Evaluation of grip strength in hook of hamate fractures treated with osteosynthesis. Is this surgical treatment necessary?
Published 2019-03-01“…Results: The mean follow-up was 36 months (range, 12–144 months). All 13 cases were treated with ORIF of the hook of the hamate. Mean VAS pain score was 5 preoperatively (4–9) and 1 (0–2) postoperatively. …”
Get full text
Article -
411
ART to prevent vertical transmission in Latin America: where are we in the “Treat‐All” era?
Published 2025-05-01“…In the pre‐treat‐all era, 4.3% (21/485) of infants were born HIV positive, compared to 0.8% (1/128) in the treat‐all era (p = 0.055). …”
Get full text
Article -
412
Splenic volume as a predictor of survival in cancer patients treated with immune checkpoint inhibitors
Published 2025-05-01“…The meta-analysis results revealed that subjects with higher spleen volumes had a significantly reduced OS (HR: 1.74, 95% CI: 1.12–2.72, p = 0.014) and PFS (HR: 1.35, 95% CI: 1.15–1.58, p < 0.001) compared to counterparts with lower volumes. Furthermore, the data clearly highlighted that patients with increases in splenic volume faced significantly poorer clinical outcomes, as indicated by reduced OS (HR: 1.83, 95% CI: 1.36–2.46, p < 0.001) and PFS (HR: 1.70, 95% CI: 1.28–2.25, p < 0.001) relative to those with decreases in splenic size.ConclusionA higher baseline spleen volume and an increase in spleen volume during ICI therapy were predictors of a poor prognosis in cancer patients treated with ICI.…”
Get full text
Article -
413
Impact of vein-to-vein time in patients with R/R LBCL treated with axicabtagene ciloleucel
Published 2025-06-01“…We conducted a systematic literature review (SLR) and meta-analysis to identify differences in V2Vt in patients with R/R LBCL treated with axi-cel, tisa-cel, or liso-cel. The impact of V2Vt (<28 days vs ≥28 to <40 days vs ≥40 days) on effectiveness and safety outcomes was evaluated in patients treated with axi-cel enrolled in a post-authorization safety study using the Center for International Blood and Marrow Transplant Research data. …”
Get full text
Article -
414
-
415
Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator
Published 2025-04-01“…Methods In a multicentre international registry, we retrospectively collected data from a consecutive series of 1003 patients. …”
Get full text
Article -
416
Characterizations of multi-kingdom gut microbiota in immune checkpoint inhibitor-treated hepatocellular carcinoma
Published 2024-06-01“…Herein, we investigated the multi-kingdom microbiota characterization of the gut microbiome, mycobiome, and metabolome using metagenomic, ITS2, and metabolomic data sets of 80 patients with ICI-treated HCC.Results Our findings demonstrated that bacteria and metabolites differed significantly between the durable clinical benefit (DCB) and non-durable clinical benefit (NDB) groups, whereas the differences were smaller for fungi. …”
Get full text
Article -
417
[Translated article] Musculoskeletal injuries treated following the flood in October 2024 in Valencia, Spain
Published 2025-09-01“…Introduction: The aim of this study was to describe and analyze the musculoskeletal injuries treated at a tertiary hospital, resulting from the sudden flooding and landslides that occurred on October 29, 2024, in the province of Valencia, Spain. …”
Get full text
Article -
418
Different features of acute myeloid leukemia stem cell quantification in intensively treated patients
Published 2025-04-01Get full text
Article -
419
-
420